Adultspan Journal
Volume 7

Issue 1

Article 2

4-1-2008

Providing Counseling for Individuals With Alzheimer’s Disease and
Their Caregivers
Paul F. Granello
Matthew S. Fleming

Follow this and additional works at: https://mds.marshall.edu/adsp

Recommended Citation
Granello, Paul F. and Fleming, Matthew S. (2008) "Providing Counseling for Individuals With Alzheimer’s
Disease and Their Caregivers," Adultspan Journal: Vol. 7: Iss. 1, Article 2.
DOI: Available at: https://mds.marshall.edu/adsp/vol7/iss1/2

This Practitioner Focused Article is brought to you for free and open access by Marshall Digital Scholar. It has been
accepted for inclusion in Adultspan Journal by an authorized editor of Marshall Digital Scholar. For more
information, please contact zhangj@marshall.edu, beachgr@marshall.edu.

Granello and Fleming: Providing Counseling for Individuals With Alzheimer’s Disease and

Providing Counseling for
Individuals With Alzheimer’s
Disease and Their Caregivers
Paul F. Granello and Matthew S. Fleming
Alzheimer’s disease is a progressive condition that results in brain wasting and
eventual death. With its increasing diagnosis rate, counselors will likely acquire
clients with Alzheimer’s disease or their caregivers. Important background
information and several practical counseling methods are provided that may
assist counselors working with this population.
Alzheimer’s disease is a progressive, fatal condition that results in brain wasting and
eventual death. Approximately 4.5 million Americans currently have Alzheimer’s
disease, and the likelihood of being diagnosed with Alzheimer’s disease increases
to nearly 50% by age 85 (Hodes, 2004). The annual economic cost of Alzheimer’s
disease on the American economy is estimated to be more than $100 billion.
Furthermore, as the median age of the American population increases over the
next several decades, the number of individuals diagnosed with Alzheimer’s disease
is projected by Hodes to increase to more than 13 million by 2050.
In the future, counselors will likely encounter clients who are diagnosed with
Alzheimer’s disease or who are caregivers of someone with the disease. The purpose of this article is to provide counselors with a summary of the implications
of Alzheimer’s disease and strategies for managing therapy with people whose
lives are affected by Alzheimer’s. By familiarizing themselves with information
regarding the theories of etiology, behavioral effects, symptoms, diagnostic
methods, current medical treatments, specific counseling considerations, and
treatment interventions for those with Alzheimer’s and for their caregivers,
counselors can become better prepared to work with these clients.

Etiology of Alzheimer’s Disease
A prominent manifestation of Alzheimer’s is the formation of plaques and tangles
of abnormal neurons in specific areas of the person’s brain. The presence of plaques
and tangles are characteristic of Alzheimer’s disease, and the absence of one of these
features means that Alzheimer’s cannot be diagnosed. The plaques and neuron
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tangles found in the brain of an individual with Alzheimer’s are indicative of a
general wasting of the brain that leads to progressive cognitive impairment, which
is characteristic of the disease. Cognitive impairment results in confusion during
early stages of Alzheimer’s disease. As the impairment worsens, the person with
Alzheimer’s disease gradually loses the ability to manage day-to-day activities such
as dressing and hygiene. Eventually, those with Alzheimer’s disease are unable to
care for themselves and reside in a vegetative state until death.
The underlying cause of plaque formation is known to be related to harmful
neurochemical processes (beta-amyloid peptides between cells and highly ordered
aggregates of abnormal brain protein called tau within cells; Davies, 2000). Currently, experts in the field posit abnormal gene mutations as a potential basis for
Alzheimer’s disease (Davies, 2000). However, the three known genetic mutations
related to the disease account for only about 0.5% of the cases of Alzheimer’s
disease, leaving the preponderance of cause still largely unknown.
Another hypothesis for Alzheimer’s disease is impaired cerebromicrovascular
perfusion (De La Torre, 2000). De La Torre proposed that, as part of the aging
process, brain capillaries degenerate and fail to deliver adequate perfusion to
brain cells to deliver glucose to neurons and remove waste products. De La Torre
provided a number of factors to support his particular theory for Alzheimer’s
disease, including findings that the majority of individuals with Alzheimer’s
exhibit microvascular abnormalities and drugs that improve cerebral perfusion
lower the risk of Alzheimer’s disease.
Persson and Skoog (1996) indicated that psychosocial risk factors may also
contribute to the development of Alzheimer’s disease. They identified major life
stressors such as experiencing the death of a spouse, death of a child, death of a
parent before reaching age 16. Their study’s participants who identified experiencing more than three stressors had an incidence of Alzheimer’s disease of 20%
in comparison with an incidence of 3% for participants not experiencing any of
the identified stressors. Just as it has been linked to many other diseases, chronic
stress combined with other health factors may be a contributor to Alzheimer’s.
Regardless of whether gene mutation, brain blood circulation, stress, or some
other factor is eventually found to be the underlying cause of Alzheimer’s disease,
diagnosis remains difficult. Additionally, the cognitive, social, and behavioral effects of the disease greatly influence the person’s ability to function independently.
Counselors, by the nature of their scope of practice, will focus treatment interventions on the psychosocial and behavioral aspects of the disease. The following
sections describe Alzheimer’s disease diagnosis and effects and the importance of
counseling for those with the disease and for their caregivers.

Diagnosis of Alzheimer’s Disease
Diagnosis of Alzheimer’s disease is made through evaluation of an individual’s
mental status and through use of other neurological tests to evaluate language,
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memory, reasoning, and physical condition (Alzheimer’s Association, 1997).
Because one definitive test for Alzheimer’s disease does not exist, practitioners
use multiple modalities to rule out other possible causes of dementia. Typically,
such modalities include using brain imaging to rule out strokes and medical
tests to check for other contributing conditions.
Importance of Early Diagnosis
Alzheimer’s disease progresses over time, starting with minor changes in cognitive ability and ending with severe cognitive compromise and death. Because of
the availability of medications that might slow the progression of this disease
and the promise of more to come, researchers are trying to determine whether
straightforward mechanisms for early diagnosis of Alzheimer’s disease exist. A
recently published paper by Amieva et al. (2005) followed nearly 1,300 older
people for a period of 10 years. During that time, participants were evaluated
psychologically and neurologically for dementia every 2 years. Amieva et al.’s
study suggested that cognitive decline in individuals with Alzheimer’s as a group
can be demonstrated up to 9 years before a clinical diagnosis. In addition, the
cognitive decline seemed to accelerate in the 3 years preceding a diagnosis.
Whereas this research did suggest statistical significance of the mental declines
within the groups, it does not show evidence that these declines are diagnostic
for an individual.
Given that mental decline due to Alzheimer’s disease occurs over many years,
early diagnosis might offer a chance to use medications and other preventative
strategies when they can do the most good (Nordberg, 2003). Early prescription
of drugs might delay the advent of Alzheimer’s disease symptoms or slow their
progression; however, this has not been demonstrated because of the medication treating Alzheimer’s symptoms rather than its cause and the difficulty in
identifying the onset date of the disease.
Difficulty With Diagnosis
Early stage Alzheimer’s disease is difficult to diagnose because the early, low-level
confusion and memory loss do not greatly differ from what are experienced as a
typical part of aging. Furthermore, many of the traits associated with Alzheimer’s
disease such as memory loss and anxiety also are typical of mood disorders
(Goldman, 2001). Tools that are used to identify the status of those diagnosed
with Alzheimer’s are not specific enough to give definitive diagnosis of early stage
disease. For example, the Mini-Mental State Examination (MMSE) is effective
at identifying the current status of someone’s mental state and is commonly used
in measuring the mental status of individuals with Alzheimer’s disease. However,
the MMSE does not discriminate sufficiently between person-to-person mental
status variability and variability due to pathology to be an accurate measure of
the status of Alzheimer’s disease or to diagnose Alzheimer’s disease in its early
state (McCarten, Rottunda, & Kuskowski, 2004). The MMSE is often used to
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measure an individual’s status repeatedly over several years, thereby detecting
changes in mental status that could lead to diagnosis of Alzheimer’s disease.
Verbal functioning is a popular neuropsychological test method for Alzheimer’s
disease (Forbes, Shanks, & Venneri, 2004). As Alzheimer’s progresses, both spoken and
written linguistic abilities decline. Instruments such as the Boston Diagnostic Aphasia
Examination (Forbes et al., 2004) and the Boston Naming Test (Testa et al., 2004)
assess written and spoken language and are useful in identifying cognitive deficits.
The use of neuropsychological tests to diagnose Alzheimer’s is somewhat controversial from the perspective of the relative value of these tests as stand-alone
tools. The ability to both remember words and construct complex sentences
declines with the progression of Alzheimer’s disease, so the idea to use these
types of tests to diagnose early stage Alzheimer’s is attractive. However, as with
the MMSE, too much variability seems to exist to use these tests effectively on
a stand-alone basis (Testa et al., 2004).
Neuropsychological tests can suggest the presence of underlying neurological
pathology such as Alzheimer’s. However, many of those tested will be placed in
the category of mild cognitive impairment (MCI) in which impairment is too
slight to be a basis for the diagnosis of Alzheimer’s disease. Zamrini, De Santi,
and Tolar (2004) suggested that 12% to 14% of those with MCI will eventually
present with Alzheimer’s disease. They have suggested that imaging modalities
such as positron emission tomography (PET) and magnetic resonance imaging
(MRI) could be used to demonstrate brain abnormalities typical of Alzheimer’s
disease long before neuropsychological tests could be used to make a definite
diagnosis. Specific areas implicated in brain pathology are degeneration in
the areas of the entorhinal cortex and hippocampus. MRI and PET can show
brain atrophy clearly in those with full-blown Alzheimer’s disease. Conversely,
Csernansky et al. (2005) concluded that the only feature consistently predicting
progression of MCI to Alzheimer’s was an asymmetric feature in the hippocampus. No other studies have indicated any asymmetries in the progression
of Alzheimer’s disease. Therefore, the findings of Csernansky et al. indicate a
need for further research before imaging techniques are relied upon for clinical
diagnosis of a disease that most people view as a death sentence.
Research into the utility of an earlier diagnosis of Alzheimer’s has yet to
demonstrate that early diagnosis allows doctors to alter the course of the disease
significantly. However, demonstrations of early detection of brain pathology are
necessary to facilitate future research into drugs that may arrest this pathology
before it causes clinical impairment (Zamrini et al., 2004).

Psychosocial and Behavioral Effects of Alzheimer’s
The gradual loss of memory and reasoning capabilities result in high levels
of stress for those diagnosed with Alzheimer’s disease and for their caregivers.
People with Alzheimer’s gradually become less and less able to function in
16
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society. Routine tasks such as paying bills, going to the store, taking scheduled
medications, or even getting dressed require too much mental processing and
planning to complete for people with Alzheimer’s disease. This loss of ability to
function creates tremendous stress for those with Alzheimer’s. They experience
the immediate stress of not being able to function and complete tasks necessary
to live independently. Many individuals experience shame associated with their
inability to live up to their own expectations of how they should live their life.
Eventually, as cognitive abilities decline further, people with Alzheimer’s also
experience a loss of the ability to comprehend many instructions or to understand
what is happening around them, which results in confusion and fear.
Continuum of Disease Progression
Alzheimer’s is a chronic disease in which the early symptoms may be apparent
more than 12 years prior to the eventual death of the individual (McMahon &
Lacy, 2005). As with many chronic illnesses, individuals with Alzheimer’s will
commonly follow a predictable progressive course of increasing disability.
In the early stages of the disease, the symptoms may be relatively mild. Symptoms may manifest as forgetfulness; however, people with early stage Alzheimer’s
often remain employed. They may live alone or at home with a companion.
Those with mild Alzheimer’s may still be able to perform calculations necessary
for balancing their checkbooks and paying their bills.
At middle and later stages of the disease, usually within 5 years of death,
individuals may lose the ability to dress unaided. Disease progression continues
with loss of the ability to toilet and shower unaided, and loss of bowel and
urine control perhaps 2 to 3 years prior to death. Speaking ability declines until
individuals with Alzheimer’s have command of only five or six words. Eventually,
they lose all ability to speak, sit up, or even smile. Clinicians must understand
and plan treatment interventions that are relevant to the stage (early, middle,
late) of the disease their clients are experiencing.
Common Behaviors
Behaviors often exhibited by individuals with Alzheimer’s disease include
anger and agitation; hallucinations and paranoia; repetitive actions; screaming
and verbal noises; incontinence; problems with bathing, dressing, eating, and
sleeping; wandering; and wanting to go home when they cannot (Robinson,
Spencer, & White, 1989). Contributing factors to these behaviors include
physiological and medical causes, environmental causes, and specific triggers
from their caregivers or others. Understanding the possible causes of these
behaviors is important because those with Alzheimer’s disease often are unable to communicate the sources of their problems. Careful and diligent
observation is necessary to determine what may be causing individuals with
Alzheimer’s to behave inappropriately and to select appropriate courses of
action to address their needs.
ADULTSPAN Journal Spring 2008 Vol. 7 No. 1
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Psychosocial Distress
Individuals with Alzheimer’s disease experience many events and emotions that
can result in psychological distress. They experience loss of control over their environments and even their own behaviors. They may experience extreme fatigue
as the quality of their sleep declines. They may experience physical discomforts
that they are unable to communicate to their caregivers. They may experience
side effects from medications that they are taking. Such experiences contribute
to feelings of being out of control, which commonly results in depression in
many individuals with Alzheimer’s disease (Robinson et al., 1989). While nursing staff or other medical caregivers generally manage many of these behaviors,
counselors working with individuals with Alzheimer’s or their caregivers would
benefit from gaining a good understanding of the interactions between causes
of behaviors and coping strategies.

Providing Counseling for Individuals With Alzheimer’s
Currently, a paucity of research literature exists regarding individual counseling
for those with Alzheimer’s disease. A search of the PsycINFO database from
1967 to the present for the terms “Alzheimer’s AND individual AND counseling” yields only 26 citations of which nearly all refer to counseling for the
Alzheimer’s caregiver. Several reasons may account for this lack of counseling
literature. One reason may be a perception on the part of counselors of the
difficulty in treating individuals whose verbal and cognitive skills are declining.
A second reason is the healthcare system’s tendency to manage the behaviors of
people with Alzheimer’s through nursing staff rather than specialized behavioral
clinicians such as counselors. A third reason is that the easy availability and
perceived cost effectiveness of medications to address symptoms of depression
and anxiety promotes chemical management rather than behavioral management of the symptoms of people with Alzheimer’s.
Counselor Self-Awareness and Preparedness
Counseling older people also presents specific challenges for counselors. Counselors need to be aware of their own biases toward older people. Such biases
can hamper counselors’ abilities to listen to their clients objectively and to
manage the situations being encountered (Newton & Jacobowitz, 1999). Older
clients often do not have the energy, means, or opportunity to demonstrate
many positive aspects of therapy that the counselor may have come to expect
from younger clients. Attitudes that stereotype older people as frail or needing
protection can prevent the therapist from realistically assessing the situation
and offering the best level of treatment.
Although individuals with Alzheimer’s and their caregivers experience similar
stages of psychological adjustment as the disease progresses, the therapist must
recognize the individual problems that each person is encountering. Therapists
18
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who can recognize their own countertransference reactions and respond to their
clients in a manner appropriate to their levels of functioning can offer much
support in relieving stress associated with Alzheimer’s disease.
Counseling for people with Alzheimer’s disease can be conceptualized as
occurring in three general categories: strategies for helping the individual
cope with decreased cognitive abilities and symptoms of the disease, strategies
for addressing emotional upset that comes from having a serious illness, and
strategies aimed at improving cognitive function and performance. Because
individuals with Alzheimer’s may spend years in the early to moderate stages
of the disease during which they remain able to communicate and respond to
others, counselors need therapies that address people’s need to live their life with
reduced cognitive abilities. In addition to these general strategies, the literature
has identified some specific approaches for working with people with Alzheimer’s
disease, such as structuring the environment; attending to nonverbals; providing education, advocacy, and support; gaining knowledge of pharmacological
therapies; and offering validation and redirection.
Structure the Environment
Many aspects of helping individuals with Alzheimer’s involve structuring their
environment to provide cues that help them to live effectively. Counselors typically are not involved directly with addressing these needs; however, knowledge
in this area can be helpful because counselors may be called on to provide
educational services to caregivers.
Individuals with Alzheimer’s have difficulty focusing and planning; therefore,
structuring their environment becomes very important (Robinson et al., 1989).
People with dementia sometimes find the physical spaces in which they live too
confusing. Keeping living spaces relatively small to restrict the amount of detail
individuals must assimilate is helpful. Smaller living spaces also tend to limit
social interaction to small groups, which also helps to reduce confusion.
Excessive stimulation also contributes to confusion for individuals with
dementia (Robinson et al., 1989). Reducing clutter in their environment
can be helpful. Decrease stimulation by removing extraneous materials from
shelves and tabletops, eliminating unused furniture, and generally simplifying their living spaces. Stimulation also comes from music playing during
conversations, too many people participating in conversations, and other
extraneous noise.
People with Alzheimer’s have difficulty with “ordinary” aspects of their
environment such as finding the way to the bathroom or simply walking
across the floor (Robinson et al., 1989). Strategies to address this problem
include labeling locations with signs, for those who can still recognize text, or
using colored awnings above doors to help identify specific rooms. Those with
Alzheimer’s do not see as well, so lighting and floor surfaces become important.
Patterned flooring may be confusing because people with Alzheimer’s have
ADULTSPAN Journal Spring 2008 Vol. 7 No. 1
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difficulty determining whether the surface is flat, ramped, or involves stairs.
Glare from lighting may also contribute to confusion about the solidity of
floors and fear of falling on steps.
Increased Importance of Nonverbal Cues
Some attempts have been made to involve individuals with Alzheimer’s disease
in group work. Their living environments in adult day care or nursing homes
make gathering people relatively easy, and the group work can be structured as
one of their daily activities. Junn-Krebs (2003) described the development of
groups for those with Alzheimer’s and the group leader’s role. In these groups,
the leader must assume a much more active role to draw individuals toward
participation in the group. Attention to nonverbal cues such as facial expression
becomes critical because some participants may be capable of providing only
that form of feedback. The group leader needs to acknowledge nonverbal cues
and work to build cohesiveness based upon them.
LaBarge, Rosenman, Leavitt, and Cristiani (1988) conducted a study
in which they divided participants with mild dementia into groups that
received counseling and control groups that did not receive counseling.
The participants indicated that they enjoyed participating in the groups;
however, no pre- or postparticipation statistical difference existed between
treatment and control groups in measures from the State-Trait Personality
Inventory or the Self-Concept scale. LaBarge et al. noted that their study
excluded those with identified depression who might have shown more
marked improvement through therapy.
Counselors need to recognize that many behaviors of those with organic
brain disease are beyond control of the individual and that the individual
may or may not be aware of what he or she is doing (Vickers, 1994). This
realization needs to be incorporated into the counselor or caregiver’s reactions to the individual because, somewhat paradoxically, many people with
Alzheimer’s develop heightened awareness of body language. Therefore, any
irritation or aversion present in the motions or bearing of the caregiver will
influence the individual and that influence may be more significant than the
influence of verbal directions.
Providing Education, Advocacy, and Support
Providing education about Alzheimer’s disease to clients who may have significant
fears following their initial diagnosis is a very valuable role for the counselor.
In addition to general disease education, information about coping strategies,
community resources, and assistance in developing “disease management plans”
are resources that counselors can provide. Furthermore, advocating for clients
with health care providers, providing emotional support, and helping clients
to martial their social support systems are important therapeutic services that
a counselor can provide to the Alzheimer’s client.
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Knowledge of Pharmacological Therapies
Counselors working with clients should familiarize themselves with the therapeutic
benefits and side effects of any medications their clients are taking. Counselors, while
not prescribing medications, have an important role in educating clients and caregivers about medications, encouraging compliance, and advocating for clients with
physicians concerning medication adjustments. As with most individuals diagnosed
with chronic diseases, those with Alzheimer’s are commonly prescribed medications
to help with cognitive decline and behavioral symptoms. Several drugs recently approved for treating cognitive decline are specifically indicated for Alzheimer’s disease.
Most of these are in a class of drugs called cholinesterase inhibitors (Alzheimer’s Association, n.d.). Cholinesterase inhibitors have the effect of increasing the level of
the neurotransmitter acetylcholine, which in turn improves cognition and memory.
Drugs in this class include donepezil (marketed as Aricept), galantamine (marketed
as Reminyl and renamed Razadyne), and rivastigmine (marketed as Exelon).
Cholinesterase inhibitors have relatively minor side effects, which can include
nausea, vomiting, and loss of appetite. The Alzheimer’s Association provides
a useful handout on its Web site that explains the effect of these drugs and is
suitable for individuals with Alzheimer’s and their caregivers (http://www.alz.org/
documents/national/FS_cholinesteraseinhibtors.pdf ).
Memantine (marketed as Namenda) is a newer drug that works on different
chemical pathways than do the cholinesterase medications. This drug reduces
excess glutamate present in the brain, which influences calcium flow into the
nerve cells. Memantine has been clinically demonstrated to produce improved
memory and function in individuals with Alzheimer’s. The Alzheimer’s Association also provides a useful memantine handout on its Web site (http://www.
alz.org/documents/national/FSmemantine.pdf ).
Medications are frequently used by physicians in treating behavioral symptoms
in Alzheimer’s disease. Medications in the antidepressant class known as selective
serotonin reuptake inhibitors (SSRIs) are prescribed for low mood and irritability
or depression that often accompany Alzheimer’s disease (Alzheimer’s Association, 2007). These drugs, such as citalopram (marketed as Celexa), fluoxetine
(marketed as Prozac), paroxetine (marketed as Paxil), and sertraline (marketed
as Zoloft), are generally well tolerated with minor side effects.
Atypical antipsychotic drugs are also prescribed to treat symptoms such as hallucinations, delusions, aggression, and uncooperativeness (Alzheimer’s Association,
2007). These drugs, which were developed to address schizophrenia, affect a variety
of neurotransmitters in the brain and are generally well tolerated. However, the U.S.
Food and Drug Administration (FDA) has issued a product alert that these medications can increase the incidence of death in older people (FDA, 2005). A small
number of people experienced symptoms such as neuroleptic malignant syndrome,
tardive dyskinesia, high blood sugar and diabetes, and strokes. The FDA has not
stated that these drugs should not be used but that physicians should be aware of
and monitor for these potential complications.
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Antianxiety or Anxiolytic drugs, such as lorazepam (marketed as Ativan) or oxazepam (marketed as Serax), are often prescribed for individuals with Alzheimer’s
disease to address anxiety, restlessness, or verbally disruptive behavior (FDA,
2005). These medications are in a class of drugs called benzodiazepines and are
sedative drugs (Sadock & Sadock, 2003). Because sedation can contribute to
dizziness, falls, and confusion, these drugs are to be used sparingly.
Validation and Redirection
One of the more important techniques that is effective with difficult behaviors
is validation and redirection (Gordeau & Hillier, 2005). When individuals with
Alzheimer’s become upset by something, such as thinking that someone has stolen
something from their room, counselors can intervene to help address the situation. First, counselors validate feelings by acknowledging that they understand the
individuals’ belief of being wronged and confirming that they will help find the
perpetrators of the wrong. Then, counselors redirect by asking the individuals to
do something that interests them or at which they are good. The validation helps to
calm individuals and the redirection shifts their focus to new, positive activities.

Importance of Providing Counseling for Caregivers
Providing counseling to individuals with Alzheimer’s may be essentially triadic
in nature, given that almost all of these people will have some type of caregiver.
Counselors must realize that the quality of life of individuals with Alzheimer’s
is often directly related to the mental and physical health of their caregivers.
Counselors, therefore, should include supportive therapy for the caregivers of
individuals with Alzheimer’s disease.
Caregiver Stress
Caregivers for individuals with Alzheimer’s experience high levels of stress. That
stress can result in depression or even premature death of the caregiver. Schulz and
Beach (1999) found that older caregivers of spouses with a disability who reported
experiencing strain had a 63% higher mortality rate than older people whose
spouses did not have a disability. Studies have suggested a number of factors that
may contribute to increased mortality, including caregivers being less likely to address their own health issues while giving care, having decreased immune function,
experiencing cardiovascular changes, and healing from wounds more slowly.
Counseling for family members caring for individuals with Alzheimer’s
needs to address the stress encountered by the caregivers. Therapy for caregivers can include combinations of individual therapy, group and family therapy,
or informal support groups (Frazer, 1999). Stress for caregivers can directly
result from the burden of care required by individuals with Alzheimer’s but
also from disagreements with relatives (particularly siblings) regarding care
decisions. Stress commonly results in depression and anxiety for the primary
22
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caregiver. Treatment can involve a combination of information, stress management techniques, social support establishment, and education to help the
caregiver address problems encountered.
Caregiver Depression
In one study of 790 caregivers, the prevalence of major depressive disorder
meeting diagnostic criteria was more than 22% (Cuijpers, 2005). This rate was
noted as being higher than the typical rate of depression in older people, which
was stated as being around 10%. Depression may be a contributing factor to
caregiver mortality as noted in Schulz and Beach (1999).
Awareness of depression in caregivers is critical because many caregivers
spend all their energy tending to the needs of their wards and neglect their
own health (Lu & Austrom, 2005). Caregivers with more severe depression
tended to have more psychological distress and more physical symptoms that
limited their ability to give care to their loved ones. In addition, those with
more severe depression tended to be less likely to seek professional help (Lu
& Austrom, 2005). These findings highlight the need for counselors working
with older populations to perform outreach in an attempt to address the needs
of this population.
Importance of Education for Caregivers
Just as educating individuals with Alzheimer’s is a very valuable aspect of counseling,
so too is educating their caregivers. Counselors working with caregivers can produce
considerable relief through education on effective strategies for providing care.
Education is important to help caregivers understand how to effectively deal
with needs of the individual with Alzheimer’s. Reference books such as Understanding Difficult Behaviors: Some Practical Suggestions for Coping With Alzheimer’s Disease and
Related Illnesses (Robinson et al., 1989) and Alzheimer’s Essentials: Practical Skills for
Caregivers (Gordeau & Hillier, 2005) can provide a framework for understanding
the changing needs of individuals with Alzheimer’s and help caregivers take less
personally the behaviors of these individuals that result from the disease.
Education can also reduce caregiver stress through knowledge of what
resources to apply to care for the individual with Alzheimer’s. Being able to
anticipate the stages of Alzheimer’s and being equipped to manage the ongoing disease progression are enhanced through education. Better care through
education will result in less distress for the individual with Alzheimer’s.
Kaufer, Borson, Kershaw, and Sadik (2005) found that effective treatment of
the individual with Alzheimer’s through pharmaceuticals benefited both the
individual and the caregiver. Effective pharmacological treatment of the individual with Alzheimer’s resulted in measurable decreases in caregiver distress
and reduced time spent by the caregiver in managing distress in the individual
with Alzheimer’s. Therefore, an overall benefit to caregivers is produced when
education helps in the delivery of effective, efficient care.
ADULTSPAN Journal Spring 2008 Vol. 7 No. 1

Published by Marshall Digital Scholar, 2008

23
11

Adultspan Journal, Vol. 7, Iss. 1 [2008], Art. 2

Helping Caregivers Engage Social Supports
Counselors should consider referring caregivers to the local chapters of the Alzheimer’s
Association. The Alzheimer’s Association offers numerous resources to the caregiver
including education, support, respite care, information about medical treatments,
information about doctors and legal issues. Counselors should also aid caregivers
in forming support systems. In addition to individual counseling, many sources
of support groups for caregivers exist. Such groups are often offered through local
chapters of the Alzheimer’s Association and nursing homes.

Summary
Alzheimer’s has significant mental health implications for the people diagnosed
with this disease and for those who care for them. Counselors can help ameliorate
severity of mental health issues by providing education and support to individuals
with Alzheimer’s and to their caregivers. Counseling efforts need to be focused on
addressing day-to-day issues. Furthermore, because depression and anxiety often are
present in individuals with Alzheimer’s and in their caregivers, counselors should be
alert for symptoms and prepared with treatment interventions. Counselors, through
their attentiveness, can help prevent the already difficult process of negotiating a
debilitating chronic illness from becoming even more unbearable.
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